Dari Fiksi ke Fakta: Keunggulan Nanoteknologi dalam Pengobatan Modern

Referensi:

Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007). Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology, 2(12), 751-760. 

Bawa, R., et al. (2016). Nanotechnology-Based Drug Delivery Systems. Taylor & Francis. 

Davis, M. E., Chen, Z., & Shin, D. M. (2008). Nanoparticle therapeutics: an emerging treatment modality for cancer. Nature Reviews Drug Discovery, 7(9), 771-782. 

Mura, S., Nicolas, J., & Couvreur, P. (2013). Stimuli-responsive nanocarriers for drug delivery. Nature Materials, 12(11), 991-1003. 

Saraiva, C., Praa, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016). Nanoparticlemediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases. Journal of Controlled Release, 235, 34-47. 

Sumer, B., & Gao, J. (2008). Theranostic nanomedicine for cancer. Nanomedicine, 3(2), 137-140.

Petros, R. A., & DeSimone, J. M. (2010). Strategies in the design of nanoparticles for therapeutic applications. Nature Reviews Drug Discovery, 9(8), 615-627. 

Zhang, L., Gu, F. X., Chan, J. M., Wang, A. Z., Langer, R. S., & Farokhzad, O. C. (2008). Nanoparticles in medicine: therapeutic applications and developments. Clinical Pharmacology & Therapeutics, 83(5), 761-769.

Farokhzad, O. C., & Langer, R. (2009). Impact of nanotechnology on drug delivery. ACS Nano, 3(1), 16-20